Skip to main content
. Author manuscript; available in PMC: 2019 Dec 28.
Published in final edited form as: Cancer Lett. 2018 Sep 19;439:56–65. doi: 10.1016/j.canlet.2018.09.024

Figure 4.

Figure 4.

The pan-PI3K inhibitor GDC0941 has overlapping effect with BKM120. A, dose-response assays showing synergy between GDC0941 and Volasertib (BI6727) in two ATC cell lines. B, GDC0941 suppresses the 8N population induced by Volasertib (BI6727).